Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nathanael S. Gray
THZ1 Targeting CDK7 Suppresses STAT Transcriptional Activity and Sensitizes T-Cell Lymphomas to BCL2 Inhibitors
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Development of Covalent Inhibitors That Can Overcome Resistance to First-Generation FGFR Kinase Inhibitors
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Genomic and Pathological Heterogeneity in Clinically Diagnosed Small Cell Lung Cancer in Never/Light Smokers Identifies Therapeutically Targetable Alterations
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Conformational Flexibility and Inhibitor Binding to Unphosphorylated Interleukin-1 Receptor–associated Kinase 4 (IRAK4)
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Correction: An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1.
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
A Broad-Spectrum Antiviral Molecule, QL47, Selectively Inhibits Eukaryotic Translation
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
A Multi-Targeted Probe-Based Strategy to Identify Signaling Vulnerabilities in Cancers
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Development of Selective Covalent Janus Kinase 3 Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
A Type-Ii Kinase Inhibitor Capable of Inhibiting the T315I “Gatekeeper” Mutant of BCR-Abl
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Ibrutinib Targets Mutant-Egfr Kinase With a Distinct Binding Conformation
Oncotarget
Oncology
1
2
›
